FOXO1 is an essential regulator of pluripotency in human embryonic stem cells

Nature Cell Biology

Volumn 13, Issue 9, 2011, Pages 1092-1101

  Zhang, Xin ^a   Yalcin, Safak ^a   Lee, Dung Fang ^a   Yeh, Tsung Yin J ^b   Lee, Seung Min ^a   Su, Jie ^a   Mungamuri, Sathish Kumar ^a   Rimmelé, Pauline ^a   Kennedy, Marion ^c   Sellers, Rani ^d   Landthaler, Markus ^e,f   Tuschl, Thomas ^e   Chi, Nai Wen ^b   Lemischka, Ihor ^a   Keller, Gordon ^c   Ghaffari, Saghi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOLOGY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LONGEVITY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; DOXYCYCLINE; EMBRYONIC STEM CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-3; PHOSPHORYLATION; PLURIPOTENT STEM CELLS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SOXB1 TRANSCRIPTION FACTORS;

EID: 80052490840     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2293     Document Type: Article

References (53)

1. Boyer, L. A., Mathur, D. & Jaenisch, R. Molecular control of pluripotency. Curr. Opin. Genet. Dev. 16, 455-462 (2006). (Pubitemid 44345206)
2. Niwa, H. How is pluripotency determined and maintained? Development 134, 635-646 (2007). (Pubitemid 46437906)
3. Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008). (Pubitemid 351253686)
4. Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998). (Pubitemid 28507326)
5. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003). (Pubitemid 36694189)
6. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003). (Pubitemid 36694188)
7. Avilion, A. A. et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140 (2003). (Pubitemid 36062514)
8. Paik, J. H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323 (2007).
9. Miyamoto, K. et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1, 101-112 (2007). (Pubitemid 46865800)
10. Yalcin, S. et al. Foxo3 is essential for the regulation of Ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J. Biol. Chem. 283, 25692-25705 (2008).
11. Renault, V. M. et al. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5, 527-539 (2009).
12. Naka, K. et al. TGF-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463, 676-680.
13. Yalcin, S. et al. ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice. EMBO J. 29, 4118-4131 (2010).
14. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005). (Pubitemid 41345211)
15. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
16. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
17. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
18. Ogg, S. et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-999 (1997). (Pubitemid 27485694)
19. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999). (Pubitemid 29165088)
20. Kops, G. J. et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630-634 (1999). (Pubitemid 29183692)
21. Essers, M.A. et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23, 4802-4812 (2004). (Pubitemid 40069710)
22. Hu, M. C. et al. IB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225-237 (2004). (Pubitemid 38496242)
23. Yang, W., Dolloff, N. G. & El-Deiry, W. S. ERK and MDM2 prey on FOXO3a. Nat. Cell Biol. 10, 125-126 (2008). (Pubitemid 351194041)
24. Mahmud, D. L. et al. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 21, 1556-1562 (2002). (Pubitemid 34226143)
25. Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015 (2004). (Pubitemid 38393275)
26. Daitoku, H. et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl Acad. Sci. USA 101, 10042-10047 (2004). (Pubitemid 38891191)
27. Huang, H. et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitinmediated degradation. Proc. Natl Acad. Sci. USA 102, 1649-1654 (2005). (Pubitemid 40209222)
28. Yamagata, K. et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 32, 221-231 (2008).
29. Dansen, T. B. et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 5, 664-672 (2009).
30. van den Berg, M. C. & Burgering, B. M. Integrating opposing signals toward Forkhead box O. Antioxid Redox Signal 14, 607-621 (2011).
31. Zhang, X., Rielland, M., Yalcin, S. & Ghaffari, S. Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned? Curr. Drug Targets 12 (2011).
32. Castrillon, D. H., Miao, L., Kollipara, R., Horner, J. W. & DePinho, R. A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301, 215-218 (2003). (Pubitemid 36858475)
33. Hosaka, T. et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl Acad. Sci. USA 101, 2975-2980 (2004). (Pubitemid 38327721)
34. Marinkovic, D. et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J. Clin. Invest. 117, 2133-2144 (2007). (Pubitemid 47219558)
35. Keller, G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19, 1129-1155 (2005). (Pubitemid 40696181)
36. Brandenberger, R. et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat. Biotechnol. 22, 707-716 (2004). (Pubitemid 38702827)
37. Jiang, J. et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10, 353-360 (2008). (Pubitemid 351331023)
38. Singh, S. K., Kagalwala, M. N., Parker-Thornburg, J., Adams, H. & Majumder, S. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453, 223-227 (2008). (Pubitemid 351667975)
39. Wei, C. L. et al. Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells 23, 166-185 (2005).
40. Boiani, M. & Scholer, H. R. Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 6, 872-884 (2005). (Pubitemid 41568736)
41. Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376 (2000). (Pubitemid 30187435)
42. Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4, 487-492 (2009).
43. Adewumi, O. et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25, 803-816 (2007). (Pubitemid 47052190)
44. Furuyama, T., Nakazawa, T., Nakano, I. & Mori, N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349, 629-634 (2000). (Pubitemid 30465799)
45. Watanabe, S. et al. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25, 2697-2707 (2006).
46. Ivanova, N. et al. Dissecting self-renewal in stem cells with RNA interference. Nature 442, 533-538 (2006). (Pubitemid 44167907)
47. Lee, J. Y. et al. mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Cell Stem Cell 7, 593-605 (2010).
48. Davenport, T. G., Jerome-Majewska, L. A. & Papaioannou, V. E. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development 130, 2263-2273 (2003). (Pubitemid 36656720)
49. Narducci, M. G. et al. TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc. Natl Acad. Sci. USA 99, 11712-11717 (2002). (Pubitemid 34994464)
50. Kennedy, M., D'Souza, S. L., Lynch-Kattman, M., Schwantz, S. & Keller, G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109, 2679-2687 (2007). (Pubitemid 46482058)
51. Hua, X., Miller, Z. A., Wu, G., Shi, Y. & Lodish, H. F. Specificity in transforming growth factor induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc. Natl Acad. Sci. USA 96, 13130-13135 (1999).
52. Im, H. et al. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol. Biol. 284, 129-146 (2004).
53. Lohmann, F. & Bieker, J. J. Activation of Eklf expression during hematopoiesis by Gata2 and Smad5 prior to erythroid commitment. Development 135, 2071-2082 (2008). (Pubitemid 352022521)